In silico repositioning of approved drugs against Schistosoma mansoni energy metabolism targets.
Schistosomiasis is a neglected parasitosis caused by Schistosoma spp. Praziquantel is used for the chemoprophylaxis and treatment of this disease. Although this monotherapy is effective, the risk of resistance and its low efficiency against immature worms compromises its effectiveness. Therefore, it...
Main Authors: | Nicole Melo Calixto, Daniela Braz Dos Santos, José Clecildo Barreto Bezerra, Lourival de Almeida Silva |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0203340 |
Similar Items
-
In silico repositioning-chemogenomics strategy identifies new drugs with potential activity against multiple life stages of Schistosoma mansoni.
by: Bruno J Neves, et al.
Published: (2015-01-01) -
Correction: In Silico Repositioning-Chemogenomics Strategy Identifies New Drugs with Potential Activity against Multiple Life Stages of Schistosoma mansoni.
by: PLOS Neglected Tropical Diseases Staff
Published: (2015-02-01) -
Activity Profile of an FDA-Approved Compound Library against Schistosoma mansoni.
by: Gordana Panic, et al.
Published: (2015-01-01) -
A Comparative Study of the Organic Acid Content of the Hemolymph of Schistosoma mansoni-Resistant and Susceptible Strains of Biomphalaria glabrata
by: José Clecildo Barreto Bezerra, et al.
Published: (1997-05-01) -
In Silico Analysis of Common Long Noncoding RNAs in Schistosoma mansoni and Schistosoma haematobium
by: Serhat Sirekbasan, et al.
Published: (2021-01-01)